83 related articles for article (PubMed ID: 11834544)
1. Novel immunotherapies for rheumatoid arthritis.
Richardson S; Isaacs J
Clin Med (Lond); 2013 Aug; 13(4):391-4. PubMed ID: 23908512
[No Abstract] [Full Text] [Related]
2. Not all tumour necrosis is granular necrosis: authors' response.
Fuchs TL; Chou A; Ahadi M; Sheen A; Sioson L; Mittal A; Samra J; Gill AJ
Pathology; 2023 Oct; 55(6):904-906. PubMed ID: 37544876
[No Abstract] [Full Text] [Related]
3. Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis.
Impellizzeri D; Maftei D; Severini C; Miele R; Balboni G; Siracusa R; Cordaro M; Di Paola R; Cuzzocrea S; Lattanzi R
J Mol Med (Berl); 2023 May; 101(5):569-580. PubMed ID: 36988653
[TBL] [Abstract][Full Text] [Related]
4. The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.
Lu CY; Williams KM; Day RO
Aust New Zealand Health Policy; 2007 Mar; 4():2. PubMed ID: 17331230
[TBL] [Abstract][Full Text] [Related]
5. Removing barriers for disabled people would be giant leap.
Carter JM
BMJ; 2002 May; 324(7345):1101. PubMed ID: 11991931
[No Abstract] [Full Text] [Related]
6. Treating rheumatoid arthritis with tumour necrosis factor alpha blockade.
Emery P; Buch M
BMJ; 2002 Feb; 324(7333):312-3. PubMed ID: 11834544
[No Abstract] [Full Text] [Related]
7. Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment.
Harriman G; Harper LK; Schaible TF
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I61-4. PubMed ID: 10577975
[No Abstract] [Full Text] [Related]
8. Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
Maini RN; Taylor PC; Paleolog E; Charles P; Ballara S; Brennan FM; Feldmann M
Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I56-60. PubMed ID: 10577974
[No Abstract] [Full Text] [Related]
9. Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions.
Taylor PC; Williams RO; Maini RN
Curr Dir Autoimmun; 2000; 2():83-102. PubMed ID: 11791460
[No Abstract] [Full Text] [Related]
10. Tumour necrosis factor blockade in rheumatoid arthritis.
Breedveld FC
Clin Med (Lond); 2001; 1(2):107-9. PubMed ID: 11333452
[No Abstract] [Full Text] [Related]
11. [Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].
Mugnier B; Bouvenot G
Rev Med Interne; 2000 Oct; 21(10):854-62. PubMed ID: 11075394
[TBL] [Abstract][Full Text] [Related]
12. WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis.
Emery P; Reginster JY; Appelboom T; Breedveld FC; Edelmann E; Kekow J; Malaise M; Mola EM; Montecucco C; Sanda M; Sany J; Scott DL; Serni U; Seydoux G
Rheumatology (Oxford); 2001 Jun; 40(6):699-702. PubMed ID: 11426031
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
